BMYMP vs MRK: Valuation Comparison 2026
Side-by-side fundamentals for Bristol-Myers Squibb Company PFD CONV 2 (BMYMP) and Merck & Co., Inc. (MRK) — market cap, PE, PEG and sector. All figures from SEC filings and market data.
| Metric | BMYMP | MRK |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Current Price | $400 | $123.6 |
| Market Cap | $814.59B | $305.27B |
| PE Ratio | 112.36 | 23.41 |
| PEG Ratio | — | 1.64 |
| PEG Verdict | N/A | Fairly Valued |